You just read:

Details of HER-2/neu Class I Antigen Licensed by TapImmune published in Journal of Immunology: Antigen is a naturally processed epitope for breast cancer vaccines.

News provided by

TapImmune Inc.

Jan 22, 2013, 09:00 ET